Fluspirilene: Difference between revisions
m Protected "Fluspirilene": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{drugbox | | {{drugbox | | ||
| IUPAC_name = 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | | IUPAC_name = 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | ||
| image = Fluspirilene. | | image = Fluspirilene.png | ||
| width = 220 | | width = 220 | ||
| CAS_number = 1841-19-6 | | CAS_number = 1841-19-6 | ||
Line 25: | Line 25: | ||
| routes_of_administration = IM | | routes_of_administration = IM | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Fluspirilene''' is a [[piperidine|diphenylbutylpiperidine]] [[antipsychotic]] [[drug]], used for the treatment of [[schizophrenia]]. It is administered [[Intramuscular injection|intramuscularly]]. | '''Fluspirilene''' is a [[piperidine|diphenylbutylpiperidine]] [[antipsychotic]] [[drug]], used for the treatment of [[schizophrenia]]. It is administered [[Intramuscular injection|intramuscularly]]. | ||
It was discovered at [[Janssen Pharmaceutica]] in [[1963]]. | It was discovered at [[Janssen Pharmaceutica]] in [[1963]]. | ||
==References== | ==References== | ||
{{reflist|2}} | |||
{{Antipsychotics}} | |||
[[Category:Diphenylbutylpiperidine derivatives]] | [[Category:Diphenylbutylpiperidine derivatives]] | ||
[[Category:Drug]] | |||
[[ |
Latest revision as of 17:31, 8 April 2015
Clinical data | |
---|---|
Routes of administration | IM |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C29H31F2N3O |
Molar mass | 475.573 g/mol |
WikiDoc Resources for Fluspirilene |
Articles |
---|
Most recent articles on Fluspirilene Most cited articles on Fluspirilene |
Media |
Powerpoint slides on Fluspirilene |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Fluspirilene at Clinical Trials.gov Clinical Trials on Fluspirilene at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Fluspirilene
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Fluspirilene Discussion groups on Fluspirilene Patient Handouts on Fluspirilene Directions to Hospitals Treating Fluspirilene Risk calculators and risk factors for Fluspirilene
|
Healthcare Provider Resources |
Causes & Risk Factors for Fluspirilene |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fluspirilene is a diphenylbutylpiperidine antipsychotic drug, used for the treatment of schizophrenia. It is administered intramuscularly. It was discovered at Janssen Pharmaceutica in 1963.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Diphenylbutylpiperidine derivatives
- Drug